Metabolic Derangements in Acute Heart Failure Syndrome

The Cleveland Clinic100 enrolled

Overview

To determine the association of both neurohormonal and hemodynamic alterations associated with metabolic abnormalities in acute heart failure syndrome.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Congestive Heart Failure

Interventions

ObservationalOTHER

Pulmonary Artery pressure (PA), pulmonary capillary wedge pressure (PCWP), cardiac output (CO), and cardiac index (CI). This data will be collected after 24 ± 2 and 48 ± 2 hours of standard heart failure therapy

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult (age \> 18 yrs) patients admitted to the Heart Failure Intensive Care Unit (H22) with Acute Heart Failure Syndrome (AHFS) requiring placement of a Pulmonary Artery catheter for hemodynamically guided therapy. Exclusion Criteria: * History of Congenital Heart Disease. * Acute HF in the setting of acute myocardial infarction. * Severe Anemia * Patients listed for cardiac transplantation. * Terminal Malignancy, AIDS or CNS disease. * Concomitant sepsis, ARDS, trauma, aortic dissection, or pericardial tamponade

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.